Hi SirenB,
Well, honestly I had to look it up.......
The maker of this drug of course does not say that it is in use for RLS, but how many can. I went to this website and found this information about the drug.
http://www.cares.arthritis.arizona.edu/about.html
MOBIC Product Sheet
GENERIC NAME
Meloxicam
PRODUCT DESCRIPTION
Each MobicĀ® (meloxicam) tablet is a once-daily treatment indicated for relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis.1 The U.S. Food and Drug Administration approved MOBIC tablets in OA on April 14, 2000 and in RA on July 16, 2004. It has been shown to provide effective relief of osteoarthritis symptoms with gastrointestinal tolerability similar to placebo.2,3
INDICATION
MOBIC is indicated for relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis.4
DOSING AND ADMINISTRATION
The lowest dose of MOBIC should be sought for each patient. For the treatment of osteoarthritis, the recommended starting and maintenance oral dose of MOBIC is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily. For the treatment of rheumatoid arthritis, the recommended starting and maintenance oral dose of MOBIC is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily. The maximum recommended daily oral dose of MOBIC is 15 mg, regardless of formulation. Both doses may be given orally in a convenient, once-daily dosing regimen without regard to timing of meals.5
The starting and maintenance dose for MOBIC is 7.5mg once daily. Some patients may receive additional benefit by increasing the dose to 15mg once daily. Higher doses of MOBIC (22.5mg and greater) have been associated with an increased risk of serious GI events; therefore, the daily dose of MOBIC should not exceed 15mg.6
CLINICAL TRIALS
The use of MOBIC tablets for the treatment of the signs and symptoms of osteoarthritis was evaluated in the United States through a double-blind, controlled trial involving 464 patients treated with MOBIC tablets for 12 weeks. MOBIC tablets were shown to be effective in the treatment of osteoarthritis and demonstrated gastrointestinal tolerability similar to placebo.7
Outside the United States, the use of MOBIC for the management of signs and symptoms of osteoarthritis was evaluated in six double-blind, active-controlled trials in which a total of 9,589 patients were treated for four weeks to six months. In these trials, the efficacy of MOBIC tablets, in doses of 7.5 and 15 mg/day, was comparable to 20 mg piroxicam and 100 mg diclofenac SR (slow release) and was consistent with the efficacy seen in the U.S. trial.8
The use of MOBIC for the treatment of the signs and symptoms of rheumatoid arthritis was evaluated in a double-blind, controlled multinational trial involving 1184 patients treated with MOBIC for 12 weeks. MOBIC (7.5 mg, 15 mg and 22.5 mg daily) was compared to placebo. The primary endpoint in this study was the ACR20 response rate, a composite measure of clinical, laboratory and functional measures of RA response. Patients receiving MOBIC 7.5 mg and 15 mg daily showed significant improvement in the primary endpoint compared with placebo. No incremental benefit was observed with the 22.5 mg dose compared to the 15 mg dose.9
Higher doses of MOBIC (22.5 mg and greater) have been associated with an increased risk of serious GI events; therefore the daily dose of MOBIC should not exceed 15 mg.9
CONTRAINDICATIONS
MOBIC is contraindicated in patients with known hypersensitivity to meloxicam. It should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.10
To be honest SirenB, we all are so different that if you find something that works for you, all the best wishes to ya. It's such a trial and error thing with RLS that we use what we can that seems to help. God Bless you found something for you. Now all you need is your own supply.
We're sorry you had to find us, but we're glad to have you now. Your welcome to stick around and share like the rest of us. We're a great bunch of people in the same boat as you. Look forward to hearing from you again.
Best Wishes.